Detection of Epstein-Barr virus RNA and related antigens in non-neoplastic lymphoid lesions. by Tonoyama, Yuji et al.
Acta Medica Okayama
Volume 50, Issue 2 1996 Article 6
APRIL 1996
Detection of Epstein-Barr virus RNA and
related antigens in non-neoplastic lymphoid
lesions.
Yuji Tonoyama∗ Norihiro Teramoto† Ashit Baran Sarker‡
Tadashi Yoshino∗∗ Kazuhiko Hayashi††
Kiyoshi Takahashi‡‡ Tadaatsu Akagi§
∗Okayama University,
†Okayama University,
‡Okayama Univeristy,
∗∗Okayama University,
††Okayama University,
‡‡Okayama University,
§Okayama University,
Copyright c©1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.
Detection of Epstein-Barr virus RNA and
related antigens in non-neoplastic lymphoid
lesions.∗
Yuji Tonoyama, Norihiro Teramoto, Ashit Baran Sarker, Tadashi Yoshino,
Kazuhiko Hayashi, Kiyoshi Takahashi, and Tadaatsu Akagi
Abstract
To elucidate the latent state and reactivation of Epstein-Barr virus (EBV) in non-neoplastic
lymphoid lesions, we investigated 144 non-neoplastic lymphoid lesions by in situ hybridization
(ISH) to detect the expression of EBV-encoded small RNAs (EBER)-1 and BCRF-1 and by
immunostaining for latent membrane protein (LMP)-1 and ZEBRA. ISH for EBER-1 detected
EBER-1-positive cells (EPC) in 31 of the 144 examined lesions (22%). EPC were detected in
4 of 49 cases of nonspecific lymphoid hyperplasia, in 16 of 20 abscess-forming granulomatous
lymphadenitis (AFGL), 5 of 25 Kikuchi’s disease, and in 3 of 3 infectious mononucleosis. LMP-1
was expressed in 6 of 124 non-neoplastic lymphoid lesions (4.8%). LMP-1-positive cells were
observed in 6 of the 31 EBER-1-positive cases (19%). EPC were detected significantly more
frequently in LMP-1- and ZEBRA-positive specimens than in the LMP-1- and ZEBRA-negative
specimens. BCRF-1 was expressed in 4 of 11 cases examined: 2 of 3 AFGL, 1 of 2 Kikuchi’s
disease, and in the 1 case of atypical lymphoid hyperplasia. This study suggests that Epstein-Barr
virus is prevalent and can be reactivated in the lymph nodes effaced by destructive inflammation,
such as AFGL. Such inflammation may provide a local milieu that is conducive for EBV to enter
the lytic cycle.
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